Mike Hampton Joins as Chief Commercial Officer, and New Scientific Office Strengthens Sapio’s AI-Driven Lab Informatics Leadership Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, today announced key leadership appointments to accelerate drug discovery and redefine AI-driven lab informatics. With the appointment of Mike Hampton as Chief Commercial Officer (CCO) and the launch of a new […]

Appointment of leading financial executive supports continued commercial development Current CFO at Telesis Bio, former CFO of BioLegend Inc. Cambridge, UK: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the appointment of William J. Kullback to its Board of Directors as a Non-Executive Director (NED). Bill is […]

Today, BC Platforms (BCP), a global leader in real-world data (RWD), healthcare data management, and analytics, announces the appointment of Mukhtar Ahmed as its new Chief Executive Officer, effective February 17th, 2025. Over his 30-year career, Mukhtar has served on the boards of the National Health Service (NHS) and several venture capital and private equity-funded companies. He was […]

Recent technical progress has led the Board of Directors of Phase Holographic Imaging (PHI) to decide to focus resources on the company’s clinical product development program. In relation to this, the Board of Directors has, in discussion with CEO Anders Månsson, decided to initiate the search for a new CEO to lead the ambitious development […]

Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the appointment of Isabel S. Wells as Vice President, Information Technology and Chief Information Officer.  “I am very pleased to welcome Isabel to AMETEK. Isabel brings more than 25 years of experience in technology leadership, with a proven track record of delivering innovative IT and digital […]

BRANFORD, Conn. —  Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the formation of its Scientific Advisory Board. Comprised of distinguished experts in proteomics, genomics, bioinformatics, chemistry, and engineering, the board will play a critical role in shaping Quantum-Si’s scientific and development strategy, identifying emerging trends and applications, and strengthening engagement within […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D. to serve as an independent director on the Company’s Board of Directors beginning on February 1, 2025. Dr. Herr will serve on the Science & Technology Committee of the Board of Directors. Dr. Herr is a Chancellor’s Professor of Bioengineering at the […]

MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company’s new Global Head of Sales & Service. Mr. Ruggiero brings over two decades of experience in sales leadership within the technology and life sciences sectors. Prior to joining PacBio, […]

PacBio to leverage Chris’ extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down. MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Chris Smith to its Board of Directors, effective today. Mr. Smith is currently the Chief Executive Officer of […]

AUSTIN, Texas — Astrotech Corporation (NASDAQ: ASTC) announced the resignation of its Chief Financial Officer, Jaime Hinojosa, effective February 14, 2025.   Mr. Hinojosa will continue to serve in the CFO role until February 14, 2025, and after that time will provide transition services to the Company on a consulting basis through June 30, 2025. In connection with […]